Dergiler / Turkish Thoracic Journal / 2020 / Cilt: 21 - Sayı: 2

Histopathological Type of Lung Cancer and Underlying Driver Mutations in Patients with Chronic Obstructive Pulmonary Disease (COPD) versus Patients with Asthma and COPD Overlap: A Single-Center Retrospective Study

Sayfa
75–79
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Differences between thenumbers of other histological types of lung cancer and the numbers of driver mutations in the 2 groups of patients were not signifiant.CONCLUSION: The differences in the rate of lung cancer and prevalence of EGFR driver mutations between the patients with pureCOPD and those with ACO were not signifiant.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:OBJECTIVES: Chronic obstructive pulmonary disease (COPD) increases the risk of lung cancer.
📊
Temel Bulgular & Veri:The aim of this retrospective study was to examine the relationships between the histopathological type, frequency of epidermal growth factor receptor (EGFR) driver mutations, and anaplastic lymphoma receptor tyrosine kinase (ALK) rearrangements in thelung cancers of patients with COPD and ACO.MATERIALS AND METHODS: Patients with pure COPD (n=198) or ACO (n=318) who were admitted to our hospital were reviewedretrospectively.RESULTS: Lung cancers were identifid in 43 (21.7%) patients with pure COPD and 54 (17.0%) patients with ACO.
💡
Sonuç & Katkı:Differences between thenumbers of other histological types of lung cancer and the numbers of driver mutations in the 2 groups of patients were not signifiant.CONCLUSION: The differences in the rate of lung cancer and prevalence of EGFR driver mutations between the patients with pureCOPD and those with ACO were not signifiant.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

OBJECTIVES: Chronic obstructive pulmonary disease (COPD) increases the risk of lung cancer. The relationships between COPD andAsthma COPD Overlap (ACO), and between the histopathological types of lung cancer and driver mutations remain unclear and needfurther study. The aim of this retrospective study was to examine the relationships between the histopathological type, frequency of epidermal growth factor receptor (EGFR) driver mutations, and anaplastic lymphoma receptor tyrosine kinase (ALK) rearrangements in thelung cancers of patients with COPD and ACO.MATERIALS AND METHODS: Patients with pure COPD (n=198) or ACO (n=318) who were admitted to our hospital were reviewedretrospectively.RESULTS: Lung cancers were identifid in 43 (21.7%) patients with pure COPD and 54 (17.0%) patients with ACO. The following lungcancers types were observed: patients with pure COPD had 19 (44.2%) adenocarcinomas, 13 (30.2%) squamous cell lung carcinomas(SCC), 8 (18.6%) small cell lung carcinomas (SCLC); patients with ACO had 23 (42.6%) adenocarcinomas, 23 (42.6%) SCC, 2 (3.70%)SCLC. SCLC was signifiantly more prevalent in patients with pure COPD (p<0.05) than in those with ACO. Differences between thenumbers of other histological types of lung cancer and the numbers of driver mutations in the 2 groups of patients were not signifiant.CONCLUSION: The differences in the rate of lung cancer and prevalence of EGFR driver mutations between the patients with pureCOPD and those with ACO were not signifiant.

🔖

Bu Makaleye Atıf Yap

SAKAİ, T., HARA, J., YAMAMURA, K., ABO, M., OKAZAKİ, A., OHKURA, N., KASAHARA, K. (2020). Histopathological Type of Lung Cancer and Underlying Driver Mutations in Patients with Chronic Obstructive Pulmonary Disease (COPD) versus Patients with Asthma and COPD Overlap: A Single-Center Retrospective Study. Turkish Thoracic Journal, Cilt: 21 - Sayı: 2, 75–79. https://ajindex.com/articles/417944

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (4)

  1. Miyamoto H, Motoo, Hiraga T, et al. Clinical and pathological characteristics of lung cancer with chronic obstructive pulmonary disease. Nihon Kyobu Shikkan Gakkai Zasshi 1990;28:736-40
  2. Shimizu H, Hisamichi S, Motomiya M, et al. Risk of lung cancer by histologic type among smokers in Miyagi Prefecture. Jpn J Clin Oncol 1986;16:117-21. [CrossRef] 3. Rosenberger A, Bickeboller H, McCormack V, et al. Asthma and lung cancer risk: a systematic investigation by the International Lung Cancer Consortium. Carcinogenesis 2012;33:587-97. [CrossRef] 4. Denholm R, Schüz J, Straif K, et al. Is previous respiratory disease a risk factor for lung cancer? Am J Respir Crit Care Med 2014;190:549-59. [CrossRef] 5. Wang H, Diepgen TL. Is atopy a protective or a risk factor for cancer? A review of epidemiological studies. Allergy 2005;60:1098-111. [CrossRef] 6. Sakkal S, Miller S, Apostolopoulos V, et al. Eosinophils in Cancer: favourable or unfavourable? Curr Med Chem 2016;23:650- 66. [CrossRef] 7. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009;64:728-35. [CrossRef] 8. Sin DD. Asthma-COPD overlap syndrome: what we know and what we don't. Tuberc Respir Dis (Seoul) 2017;80:11-20. [CrossRef] 9. Nagai A. Complications of the lung. In: Committee for the Third Edition of the COPD Guidelines of The Japanese Respiratory Society. Guidelines for the Diagnosis and Treatment of COPD. 4th ed. Tokyo: The Japanese Respiratory Society 2013:24
  3. Matsunaga K, Hirano T, Kawayama T, et al. Reference ranges for exhaled nitric oxide fraction in healthy Japanese adult population. Allergol Int 2010;59:363-7. [CrossRef] 11. Junpei Saito AF, Yasuko Sato, Suguru Sato, et al. Differences of fractional exhaled nitric oxide (FeNO) levels performed using two different analyzers. Nihon Kokyuki Gakkai Zasshi 2010;48:17-22
  4. Cosio BG, Soriano JB, Lopez-Campos JL, et al. Defiing the asthma-COPD overlap syndrome in a COPD cohort. Chest 2016;149:45-52. [CrossRef] 13. Jian ZH, Lung CC, Huang JY, et al. The coexistence of common pulmonary diseases on the histologic type of lung cancer in both genders in Taiwan: a STROBE-compliant article. Medicine (Baltimore) 2014;93:e127. [CrossRef] 14. Harada T, Yamasaki A, Fukushima T, et al. Causes of death in patients with asthma and asthma-chronic obstructive pulmonary disease overlap syndrome. Int J Chron Obstruct Pulmon Dis 2015;10:595-602. [CrossRef] 15. Lim JU, Yeo CD, Rhee CK, et al.